blindness with glp 1 and GLP-1 Drugs: An Ophthalmologist Explains People Going Blind From GLP-1:

Compounded semaglutide through telehealth costs $297$497 regardless of insurance

Groundbreaking clinical trials published in late 2023 and 2024 show that semaglutide, approved in 2019 for treating diabetes and in 2021 for weight management, also reduces rates of heart disease and kidney disease, and reduces tissue and systemic inflammation

7.5 mg $626.97

While these symptoms can be uncomfortable, they typically reduce over time as the body adjusts to the medication

Some people breeze through in six weeks

Acetic acid and butyric acid in SCFAs can activate GPR41 and GPR43 and inhibit histone deacetylase activity to exert anti-inflammatory effects [171]